Comparison of ELISA and immunoassays for measurement of IgG and IgM antibody to West Nile virus in human sera against virus neutralisation

被引:47
作者
Niedrig, M.
Sonnenberg, K.
Steinhagen, K.
Paweska, J. T.
机构
[1] Robert Koch Inst, D-13353 Berlin, Germany
[2] EUROIMMUN AG, D-23560 Lubeck, Germany
[3] Natl Inst Communicable Dis, ZA-2131 Johannesburg, South Africa
关键词
West Nile virus (WNV); diagnostic; virus neutralisation; immunofluorescence; IFAT; ELISA;
D O I
10.1016/j.jviromet.2006.09.009
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Two commercial assays for the detection of IgG antibody to West Nile Virus (WNV), an indirect enzyme-linked immunosorbent assay (I-ELISA) and indirect fluorescent antibody test (IFAT), were evaluated against the virus neutralisation test. Excellent agreement with the virus neutralisation was obtained with both tests, i.e., 99.5% by I-ELISA and 100% by IFAT. The well-known serological cross-reactivity within the family of the Flaviviridae was analysed using sera with known antibodies against dengue virus, tick borne encephalitis virus and yellow fever virus. IgM and/or IgG positive sera were examined for reactivity by WNV-ELISA and WNV-IFAT. While cross-reactivity between 0 and 18.2% was recorded with IgM positive sera, there was extensive cross-reactivity of 15.7-100% with IgG positive sera. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:103 / 105
页数:3
相关论文
共 9 条
[1]   Clinical impact of timely reporting of IgM for West Nile Virus [J].
Barenfanger, J ;
Drake, C ;
Lawhorn, J ;
O'Brien, J ;
Mueller, T .
JOURNAL OF CLINICAL VIROLOGY, 2005, 34 (02) :122-124
[2]  
*CDCP, 2005, MMWR-MORBID MORTAL W, P1253
[3]  
JUPP PG, 1986, S AFR MED J, V70, P218
[4]   Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA [J].
Koraka, P ;
Zeller, H ;
Niedrig, M ;
Osterhaus, ADME ;
Groen, J .
MICROBES AND INFECTION, 2002, 4 (12) :1209-1215
[5]   Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus [J].
Levett, PN ;
Sonnenberg, K ;
Sidaway, F ;
Shead, S ;
Niedrig, M ;
Steinhagen, K ;
Horsman, GB ;
Drebot, MA .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (12) :5873-5875
[6]  
MCINTOSH BM, 1976, S AFR J SCI, V72, P295
[7]   Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA [J].
Niedrig, M ;
Lademann, M ;
Emmerich, P ;
Lafrenz, M .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1999, 4 (12) :867-871
[8]  
NIEDRIG M, 2006, UNPUB J CLIN VIROL
[9]   COMPARISON OF TECHNIQUES FOR DEMONSTRATING ANTIBODIES TO RIFT-VALLEY FEVER VIRUS [J].
SWANEPOEL, R ;
STRUTHERS, JK ;
ERASMUS, MJ ;
SHEPHERD, SP ;
MCGILLIVRAY, GM ;
ERASMUS, BJ ;
BARNARD, BJH .
JOURNAL OF HYGIENE, 1986, 97 (02) :317-329